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The Conserved Oligomeric Golgi (COG) complex is an evolutionarily conserved
hetero-octameric protein complex that has been proposed to organize vesicle tethering
at the Golgi apparatus. Defects in seven of the eight COG subunits are linked
to Congenital Disorders of Glycosylation (CDG)-type II, a family of rare diseases
involving misregulation of protein glycosylation, alterations in Golgi structure, variations
in retrograde trafficking through the Golgi and system-wide clinical pathologies. A
troublesome aspect of these diseases are the neurological pathologies such as low
IQ, microcephaly, and cerebellar atrophy. The essential function of the COG complex
is dependent upon interactions with other components of trafficking machinery, such as
Rab-GTPases and SNAREs. COG-interacting Rabs and SNAREs have been implicated
in neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease. Defects
in Golgi maintenance disrupts trafficking and processing of essential proteins, frequently
associated with and contributing to compromised neuron function and human disease.
Despite the recent advances in molecular neuroscience, the subcellular bases for most
neurodegenerative diseases are poorly understood. This article gives an overview of the
potential contributions of the COG complex and its Rab and SNARE partners in the
pathogenesis of different neurodegenerative disorders.
Keywords: conserved oligomeric Golgi complex, COG, congenital disorders of glycosylation, neurodegeneration,
glycosylation, vesicular trafficking, Rab, SNARE
INTRODUCTION
The Conserved Oligomeric Golgi (COG) complex is an evolutionarily conserved hetero-
octameric protein complex that is a proposed membrane tether during vesicular trafficking
at the Golgi apparatus (Lupashin and Ungar, 2008; Reynders et al., 2011; Miller and
Ungar, 2012; Willett et al., 2013b). COG is composed of two functionally distinct sub-
complexes lobe A (COG1-4) and lobe B (COG5-8) (Fotso et al., 2005; Ungar et al.,
2005). Secretory and transmembrane proteins make up 30–50% of all cellular proteins,
and are trafficked through the endoplasmic reticulum (ER) to the Golgi for folding
and modifications before delivery to their final destination. Secretory cargo molecules are
thought to travel through the Golgi complex mostly inside flat cisternae that are constantly
maturing in a cis-to-trans (anterograde) fashion via the so called cisternal maturation
mechanism (Glick and Malhotra, 1998). However, resident Golgi proteins and Soluble
NSF Attachment protein Receptors (SNAREs) are constantly recycled back in vesicular
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carriers to replenish the content of newly formed cis-
cisternae. COG regulates the recycling of vesicles containing
glycosylation enzymes and other resident Golgi proteins in
a trans-to-cis (retrograde) direction. An intricate assortment
of trafficking machineries including small Rab-GTPases,
SNAREs, Sec1/Munc18 (SM) proteins, vesicular coat proteins,
and tethering proteins are required for vesicular transport
(Bonifacino and Glick, 2004). Intracellular pathways rely
on these protein families at each step of vesicular transport.
Though the functional interaction between the tethers and
other trafficking regulators is not completely understood, a
multi-subunit tethering complex (MTC), like the COG complex,
may coordinate the interactions between all other components
of the trafficking machinery at the site of vesicle docking on
the target membrane for efficient fusion of the two membranes
(Cottam and Ungar, 2012; Willett et al., 2013b).
SNAREs are an essential COG partner. SNAREs catalyze the
fusion of the vesicle membrane with the target membrane by
the assembly of a quaternary SNARE complex that functions
as a zipper to coalesce the opposing lipid bilayers While
SNAREs alone have an innate ability to fuse membranes,
the SNARE regulatory proteins and tethering complexes are
thought to be necessary for physiologically relevant fusion
events (Rizo and Südhof, 2012). The COG complex interacts
with at least two Golgi SNARE complexes: the cis-Golgi
STX5/GOSR1(GS28)/YKT6/BET1L(GS15) complex; and the
trans-Golgi STX16/STX6/VTI1a/VAMP4 complex (Shestakova
et al., 2007; Laufman et al., 2009, 2013b). Additionally, SNARE
complexes that contain Sec22b, GOSR2(GS27), or SNAP29
are evidenced to interact with COG (Kudlyk et al., 2013;
Willett et al., 2013a). SNARE partner transitions connect all
compartments of the endocytic and secretory pathways. Thus,
it is likely that a defect in one trafficking step may have
a cascading effect on all other cargo trafficking steps. In
this review we will focus on those SNAREs where deficiency
was shown to be associated with neuronal abnormalities,
i.e., Ykt6, Sec22b, STX5, SNAP29, GS27, GS28, and Vti1a/b
(Table 1).
The essential function of the COG complex has been
proposed to depend not only upon SNAREs interactions, but
also interactions with Rabs (Miller et al., 2013; Willett et al.,
2013a; Figure 1). Within this context, Rabs are believed to act
as molecular switches that cycle between GDP-bound (inactive)
and GTP-bound (active) states and regulate cargo trafficking
by acting in an intracellular compartment-specific manner.
Active (GTP-bound) Rabs regulate trafficking by binding effector
molecules like tethering factors and motor proteins (D’Adamo
et al., 2014). Binding to some effectors leads to the activation
of other Rabs, in a sequence known as the Rab Cascade
(Pfeffer, 2013). Nine distinct, Golgi-localized Rabs are known
to interact with COG (Miller et al., 2013; Willett et al.,
2013b, 2014). The compartment-specific nature of these different
Rabs makes them a potential landmark for COG membrane
localization and interaction. As with the SNAREs, this review
will limit the discussion to COG partners Rab1a, Rab1b, Rab2,
Rab4a, and Rab6a that are implicated in neuronal abnormalities
(Table 1).
NEUROPHYSIOLOGICAL ABNORMALITIES
AND COG DEFECTS
Since 2004, defects in seven out of the eight COG subunits
have been associated with human Congenital Disorders of
Glycosylation (CDG)-type II, a growing family of diseases
involving malfunctions in the processing of N- and O-linked
glycans and resulting from mutations in proteins involved with
glycosylation (Wu et al., 2004; Spaapen et al., 2005; Foulquier
et al., 2006, 2007; Kranz et al., 2007; Ng et al., 2007, 2011; Paesold-
Burda et al., 2009; Reynders et al., 2009; Richardson et al., 2009;
Lübbehusen et al., 2010; Fung et al., 2012; Huybrechts et al.,
2012; Rymen et al., 2012, 2015; Kodera et al., 2015; Table 1).
Glycosylation is a highly dynamic process that occurs in the ER
and Golgi which requires an estimated two percent of the human
genome to encode the enzymes and trafficking components for
the proper maturation of newly formed glycan chains (Freeze
et al., 2014). COG deficiency can cause a redistribution of
COG-dependent Golgi resident proteins, including glycosylation
enzymes. Most COG-CDG patients have defects in sialylation
and galactosylation, as indicated by fluorescent lectin staining
of plasma membrane glycoconjugates from patient fibroblasts
and MALDI-TOF mass spectrometry of serum glycoproteins
(Foulquier et al., 2007; Kranz et al., 2007; Paesold-Burda et al.,
2009; Reynders et al., 2009; Zeevaert et al., 2009a,b). Along with
other multi-system pathologies, COG-CDG patients display mild
to severe neurological defects including hypotonia, intellectual
disability, developmental delays, epilepsy, and ataxia (Table 1).
Specific symptoms and the severity of condition appears to relate
to the COG subunit that is deficient with COG6 and COG7
patients demonstrating the most severe phenotypes (Rymen
et al., 2015). Additionaly, COG defects have not yet been
attributed to any other subtype of CDG.
Several CDGs result from mutated COG subunits that are
either severely truncated or rapidly degraded. Loss of one COG
subunit can destabilize the remaining subunits and reduce their
expression and association with the Golgi. Early studies of the
COG3 subunit invoked participation of the COG complex in
the proper distribution of Golgi enzymes. COG3 depletion by
siRNA in HeLa cells causes extensive Golgi fragmentation and
destabilization of the COG complex (Zolov and Lupashin, 2005).
COG3 and COG7 knockdown generates an accumulation of
COG complex-dependent (CCD) vesicles carrying the SNAREs
GS15 and GS28, and Golgi enzymes MAN2A1 and GALNT2
(Zolov and Lupashin, 2005; Shestakova et al., 2006). The
accumulation of CCD vesicles suggests that in COG deficient
cells a significant fraction of Golgi glycosylation enzymes are
separated from the proteins they need to modify. COG8-CDG
patient fibroblasts have decreased levels of the other lobe B
subunits (COG5, COG6, and COG7) all of which have lost their
association with the Golgi (Foulquier et al., 2007; Kranz et al.,
2007). COG lobe B destabilization was also seen in COG7-CDG
patient fibroblasts, resulting in the loss of COG6 association with
the Golgi (Kudlyk et al., 2013). The loss of COG also challenges
the function of interacting SNAREs. The endosome-to-trans-
Golgi Network (TGN) SNARE protein STX16 was mislocalized
in COG8-CDG patient fibroblasts (Willett et al., 2013a), and the
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TABLE 1 | Neurological phenotypes associated with COG and COG-interacting Rabs and SNAREs.
Protein Disorder Associated neurological manifestation References
COG PROTEINS
COG1 CDG-IIg (COG1-CDG) Cerebral atrophy, developmental delay, hypotonia Foulquier et al., 2006
COG2 CDG-II (COG2-CDG) Developmental delay, epilepsy Kodera et al., 2015
COG4 CDG-IIj (COG4-CDG) Developmental delay, epilepsy, hypotonia, lack of speech, nystagmus Reynders et al., 2009; Ng et al., 2011
COG5 CDG-IIi (COG5-CDG) Ataxia, cerebral atrophy, developmental delay, epilepsy, hypotonia Paesold-Burda et al., 2009; Fung et al., 2012;
Rymen et al., 2012
COG6 CDG-IIl (COG6-CDG)
Shaheen syndrome (SHNS)
Ataxia, cerebral atrophy, developmental delay, epilepsy, hypotonia,
optic nerve atrophy, sensoneural hearing loss
Intellectual disability
Lübbehusen et al., 2010; Huybrechts et al.,
2012; Shaheen et al., 2013; Rymen et al., 2015
COG7 CDG-IIe (COG7-CDG) Cerebral atrophy, developmental delay, epilepsy, hypotonia Wu et al., 2004; Morava et al., 2007; Ng et al.,
2007; Zeevaert et al., 2009a
COG8 CDG-IIh (COG8-CDG) Cerebral atrophy, developmental delay, hypotonia Foulquier et al., 2007; Kranz et al., 2007
SNARE PROTEINS
Ykt6 Parkinson’s Disease Trafficking defects and cytotoxicity in vitro in NRK and PC12 cell lines Hasegawa et al., 2003, 2004
Sec22b Parkinson’s Disease Trafficking defects and cytotoxicity in vitro in NRK and PC12 cell lines Hasegawa et al., 2003, 2004
STX5 Parkinson’s Disease
Alzheimer’s Disease
Trafficking defects and cytotoxicity in vitro in NRK and PC12 cell lines
Regulates processing of APP in PC12, HeLa, COS-7, and NG108-15
cell lines and primary cultures of rat hippocampal neurons
Suga et al., 2005b; Thayanidhi et al., 2010;
Rendón et al., 2013; Suga et al., 2015
SNAP29 CEDNIK-Neuro-cutaneous
syndrome
Cerebral Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma Sprecher et al., 2005; Fuchs-Telem et al., 2011
GS27 Myoclonus epilepsy/early
ataxia Parkinson’s Disease
Action myoclonus, mild cerebral atrophy, and early ataxia
Trafficking defects and cytotoxicity in vitro in NRK and PC12 cell lines
Thayanidhi et al., 2010; Corbett et al., 2011
GS28 Neurodegeneration Retinal degeneration in in vivo Drosophila photoreceptors Rosenbaum et al., 2014
Vti1a/b Neurodegeneration Perinatal lethality in double knockouts in an in vivo mouse model.
Neuronal axon tracks missing, reduced in size or misrouted
Kunwar et al., 2011; Walter et al., 2014
RAB PROTEINS
Rab1a Parkinson’s Disease Neuroprotective in C. elegans, D. melanogaster and primary rat neuron
cultures. Rescue from the neurotoxic effects of α-synuclein
Cooper et al., 2006; Gitler et al., 2008
Rab1b Alzheimer’s Disease Dominant negative mutant of Rab1b blocks trafficking of APP and
decreases the secretion of Aβ
Dugan et al., 1995
Rab2 Parkinson’s Disease Reduced expression of Rab2 can rescue Golgi fragmentation in PD
models
Rendón et al., 2013
Rab4a Neumann-Pick disease
Alzheimer’s Disease Down’s
syndrome
Reduced Rab4-dependent recycling in vitro in Neumann-Pick type A
and type C fibroblasts. Postmortem samples: increased Rab4 in
patients with AD and mild cognitive disorder Aβ partially co-localizes
with Rab4 in a mouse model of Down Syndrome
Cataldo et al., 2000; Choudhury et al., 2004;
Arriagada et al., 2010; Ginsberg et al., 2010
Rab6a Alzheimer’s Disease Dominant negative mutant of Rab6 increases the secretion of soluble
APP and decreased Aβ secretion
McConlogue et al., 1996
STX5/GS28/Ykt6/GS15 and STX6/STX16/Vti1a/VAMP4 SNARE
complexes were destabilized in both COG7- and COG8-CDG
patient fibroblasts (Laufman et al., 2013a). In a non-CDG patient
presenting intellectual disability, Shaheen et al. identified a
mutation in COG6 which resulted in reduced COG6 and STX6
protein expression (Shaheen et al., 2013). Anterograde trafficking
does not appear to be affected in cells with COG mutations,
but retrograde trafficking is affected as indicated by a partial
resistance to treatment with the transport inhibitor brefeldin A
(Steet and Kornfeld, 2006; Foulquier et al., 2007; Kranz et al.,
2007; Ng et al., 2007; Paesold-Burda et al., 2009; Reynders et al.,
2009) and by endosome-to-TGN trafficking defects elucidated by
application of Shiga toxin and SubAB toxin (Zolov and Lupashin,
2005; Smith et al., 2009). Therefore, retrograde intra-Golgi and
endosome-to-TGN sorting are particularly impaired by COG
deficiency.
NEUROPATHOLOGY AND DEFECTS IN
COG-ASSOCIATED PROTEINS
Extensive in vitro analyses in control and disease models
demonstrate that genetic deficiency in SNARE and Rab
COG partners may also result in disintegration of the
Golgi apparatus, thereby potentially influencing neurological
impairment (Table 1). Interestingly, the therapeutic implications
of studying neurodegeneration associated with defective COG
function is broader than the COG-CDG patient population
(D’Adamo et al., 2014; Rymen et al., 2015). Golgi fragmentation
is a common feature of neurodegenerative diseases (Gonatas
et al., 2006). Current theories argue that the Golgi fragmentation
seen in Alzheimer’s Disease (AD) and Parkinson’s Disease
(PD) is either a result of misfolded or aggregated proteins, or
that fragmented Golgi causes etiologically important proteins
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FIGURE 1 | Model of COG trafficking within neurons. A cartoon depicting the proposed roles for the COG complex (depicted as red shapes for lobe A and green
shapes for lobe B subcomplexes) and its interacting protein partners in Golgi trafficking: Rabs (yellow circles), and SNAREs (purple lines). Right panel:
Immunofluorescence images of COG complex subunit COG3 (top-red) and Golgi SNARE GS15 (middle-green) in rat dorsal root ganglion. Perinuclear (DAPI)
co-localization is indicated by yellow in the merged image (bottom). Scale Bar = 10µm.
to aggregate and misfold leading to further progression of
these diseases (Gonatas et al., 2006; Nakagomi et al., 2008;
Bellouze et al., 2014; Joshi and Wang, 2015). However, Golgi
fragmentation has also been linked to SNARE and Rab proteins
making it difficult to pinpoint a single disease progression. Thus,
the COG-Rab-SNARE dynamic is important for understanding
neurodegenerative phenotypes.
SNARES
Genetic deficiency in SNAREs was shown to be associated
with the progression of neurodegenerative diseases like AD
and PD. PD is marked by the presence of Lewy bodies
which are principally composed of aggregated α-synuclein.
Under physiological conditions, α-synuclein may regulate vesicle
trafficking and promote synaptic transmission by binding
directly to SNAREs and stimulating SNARE complex formation
(Burré et al., 2010; Thayanidhi et al., 2010). Overexpression of
wild type or the PD-associated mutant of α-synuclein (A53T)
leads to cytotoxicity and inhibition of ER-to-Golgi trafficking
in in vitro models which can be partially suppressed by
co-overexpression of SNAREs Ykt6 or Sec22. Ykt6—a protein
enriched in neurons—was more protective than Sec22 and
suggests a specialized role in mammals (Hasegawa et al., 2003,
2004). In vitro binding experiments also point toward the direct
interaction of α-synuclein with STX5 and GS27 along with
mutant α-synuclein which destabilizes the STX5-GS27-rbet1-
sec22b SNARE complex (Thayanidhi et al., 2010). This line of
evidence further implicates trafficking defects in bringing about
neurodegenerative cytotoxicity.
Although the exact molecular mechanisms connecting Golgi
fragmentation and disease mutations is still much under
investigation, in vitro models can be used to recapitulate Golgi
fragmentation seen in neurodegenerative disorders (Suga et al.,
2005a). Fragmentation has been recreated in vitro and can be
rescued by regulating levels of SNAREs. A STX5 knockdown
is known to induce Golgi fragmentation in HeLa cells and
cultured neurons (Suga et al., 2005a; Amessou et al., 2007). On
the other hand, in PC12 cells treated with 6-hydroxydopamine
or methamphetamine (an established in vitro PD model), a
decrease in the level of STX5 rescues Golgi fragmentation
(Rendón et al., 2013). This same study also demonstrated
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that Golgi fragmentation could intensify disease progression by
inducing α-synuclein aggregation and the formation of Lewy
bodies.
STX5 defects have also been shown to affect processing
of AD-related proteins. In AD, amyloid precursor protein
(APP) undergoes a series of proteolytic events by β- and γ-
secretases to create the amyloidogenic variants of β-amyloid
(Aβ) that are longer and more likely to form aggregates
(Peric and Annaert, 2015). Presenilins form a complex with
γ-secretase, and mutations in presenilin 1 (PS1) are the most
frequently associated mutations found in AD which result
in increased production of Aβ, or altered ratios of amyloid
peptide species (Hardy, 2006; Saito et al., 2011; De Strooper
et al., 2012). Overexpressed STX5 was shown to co-localize
with and directly bind to PS1. Further, STX5 overexpression
increased the accumulation of APP in the ER and cis-Golgi and
inhibited Aβ secretion in a neuroblastoma cell line (NG108-
15)(Suga et al., 2005b). In NG108-15 cells expressing the
familial AD mutation PS11E9, STX5 was shown to have a
decreased association with presenilin. A study of ER stress
in an AD model demonstrated that ER stressors can increase
synthesis of STX5 and its accumulation in the ER-Golgi
intermediate compartment (ERGIC) and transport vesicles.
Thus, upregulation of trafficking machinery induced by ER stress
could be a cellular mechanism for correcting the accumulation
of the amyloidogenic cleavage products of APP (Suga et al.,
2015).
As stated above, the cis-Golgi SNARE GS27 (GOSR2) binds
to α-synuclein and is part of a SNARE complex that is
destabilized by mutant α-synuclein. GS27 has also been shown
to be associated with a neurological disorder in humans.
Six patient were identified baring a mutation that results in
improper subcellular localization and loss of function of GS27
leading to symptoms common in COG-CDG patients such as
cerebral atrophy, epilepsy, and early ataxia (Corbett et al., 2011;
Table 1).
GS28 (GOSR1) is a Golgi SNARE involved in both ER-
to-Golgi and intra-Golgi transport (Nagahama et al., 1996;
Subramaniam et al., 1996), and accordingly has been shown to
be associated with three SNARE complexes (Zhang and Hong,
2001; Parlati et al., 2002; Xu et al., 2002; Siddiqi et al., 2010).
GS28 mutants have been used to study retinal degeneration
in Drosophila photoreceptors (Rosenbaum et al., 2014). Lack
of expression of GS28 in mutant flies alters trafficking and
glycosylation of rhodopsin (Rh1). The photoreceptors in these
mutants also exhibit enlarged ER and Golgi membranes and
retinal degeneration over time.
Vti1a is a TGN-localized SNARE that functions in vesicle
generation and Ca2+ channel trafficking (von Mollard et al.,
1997; Lupashin et al., 1997; Walter et al., 2014). A double
knockout of Vti1a and Vti1b genes results in progressive
neurodegeneration and perinatal lethality in a mouse model
(Kunwar et al., 2011). Single knockout of Vti1a or Vti1b
does not result in a lethal phenotype indicating overlapping
functions of these proteins. The death-after-birth clearly
demonstrates that these SNAREs are not required during
organismal development, indicating a specialized requirement
for Vti1a and Vti1b in neurons leading to neurodegeneration
in the double-knockout animals (Walter et al., 2014). Vti1a
SNARE partners, STX6 and STX16, are also required for
neurite outgrowth (Chua and Tang, 2008; Kabayama et al.,
2008).
In humans, a disease known as CEDNIK (Cerebral
Dysgenesis, Neuropathy, Ichthyosis, and Keratoderma)
syndrome has been linked with loss of function mutations
in SNAP29 (Sprecher et al., 2005; Fuchs-Telem et al., 2011).
SNAP29 is a member of the SNAP25 family that localizes to the
Golgi, endosomal, and lysosomal compartments (Steegmaier
et al., 1998). CEDNIK patients exhibit severe neuropathy
likely due to the loss of SNAP29 functional involvement in
neurotransmission (Pan et al., 2005) and trafficking within
neuroglia during active myelination (Schardt et al., 2009).
RABS
As for SNAREs, regulating levels of Rabs has been shown to
rescue Golgi fragmentation in multiple in vitro models of AD
and PD. For example, overexpression of Rab1 can rescue Golgi
fragmentation while reduced expression of Rab2 has the same
affect in PD models which demonstrates the delicate balance in
the regulatory functions of Golgi-associated Rabs (Rendón et al.,
2013). Overexpression of Rab1 was shown to be neuroprotective
in Caenorhabditis elegans, Drosophila melanogaster and primary
rat neuron cultures (Cooper et al., 2006; Gitler et al., 2008). Rab1
is a key protein in maintaining Golgi architecture and function
(Haas et al., 2007). It can also promote the restoration of ER-
to-Golgi trafficking and thus afford rescue from the neurotoxic
effects of α-synuclein (Cooper et al., 2006; Gitler et al., 2008).
Multiple Rabs are associated with processing of APP. For
example, ERGIC and cis-Golgi Rab1b-dependent trafficking
could modulate the processing of APP as demonstrated in
an in vitro system in which a dominant-negative mutant of
Rab1b blocked trafficking of APP and decreased the secretion of
Aβ (Dugan et al., 1995). trans-Golgi Rab6A is also implicated
in APP trafficking. The dominant negative mutant of Rab6
increased the secretion of soluble APP and decreased Aβ
secretion (McConlogue et al., 1996). Rab6 membrane association
is dependent upon PS1 based on studies using PS1 knockout
fibroblasts, thus implicating PS1 in vesicular trafficking (Scheper
et al., 2004).
Golgi-associated and endosomal Rab4 is important for a
specific pool of constitutively recycling endosomes which are
apparently critical for dendritic spine size. Rab4-dependent
recycling is greatly reduced in fibroblasts of patients with type
A/B Niemann-Pick disease, a sphingolipid storage disorder
which commonly manifests with neurological symptoms such
as developmental delay and dementia (Choudhury et al., 2004).
Postmortem samples revealed that Rab4 is upregulated in
patients with AD and mild cognitive disorder (Cataldo et al.,
2000; Ginsberg et al., 2010), and Aβ is known to partially co-
localize within Rab4 positive compartments in a mouse model of
Down Syndrome (Arriagada et al., 2010) indicating that defects
in endosomal sorting may underpin these disorders (Peric and
Annaert, 2015).
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CONCLUSIONS AND PERSPECTIVES
The COG complex and its Rab and SNARE partners are
evolutionarily conserved and ubiquitously expressed across
multiple tissues and organ systems in humans. Yet, neurological
symptoms are the most debilitating and troublesome clinical
manifestations of COG-associated disorders. Why is this the
case? We propose that brain-specific manifestations of COG
defects result from either COG-dependent (a) glycosylation
defects and/or, (b) trafficking defects and/or, (c) a yet unknown
neuron/neuroglia-specific function of the COG complex and its
partners.
Neuronal function critically depends on coordinated delivery
of properly modified ion channels, transporters and components
of the synaptic apparatus at the appropriate rates and over long
distances, to specific subcellular compartments. Remarkably,
the localization of the synaptobrevin homolog Snc1 is altered
in COG deficient yeast cells (Whyte and Munro, 2002). In
addition, underglycosylated low density lipoprotein receptor is
severely destabilized in CHO cells deficient for COG1 or COG2
proteins (Kingsley et al., 1986). Since glycosylation of channels,
transporters and transport regulators is essential for their correct
delivery, stability and/or activity (Gong et al., 2002; Watanabe
et al., 2004; Scott and Panin, 2014), it is reasonable to predict that
a majority of underglycosylated ion channels and transporters
may similarly be destabilized, thus altering the functionality of
COG-CDG patient neurons.
Smooth transport of cargo by the trafficking machinery is very
important during development and synaptic transmission.
Defective glycosylation of proteins and lipids disrupts
development pathways and alters brain function (Freeze et al.,
2012). COG deficient cells also display altered glycosphingolipid
biosynthesis. Complex gangliosides are sialic acid containing
glycosphingolipids synthesized sequentially, beginning with
GM3 and then extended by glycosyltransferases to the more
elaborate GM1 gangliosides. Biochemical studies revealed
decreased levels of sphingomyelin and GM3 gangliosides in
COG2 deficient CHO cells (Spessott et al., 2010a,b). Gangliosides
are ubiquitously expressed, but in the brain the expression of
gangliosides and their glycosyltransferases change dramatically
during development, from an abundance in of the precursor
GM3 to a greater abundance of GM1 (Yu et al., 1988; Kracun
et al., 1991, 1992; Ngamukote et al., 2007). Therefore, altered
glycosphingolipid biosynthesis could be another reason for the
specific neurological manifestation in COG-related congenital
disorders.
An additional factor that may add to the apparently higher
neuronal vulnerability to COG deficiency is that unlike many
other cells, neurons are non-dividing cells and hence cannot
easily dilute toxic proteins, peptides, and organelles. Another
possibility is that COG is playing a specific and yet uncovered role
in neuronal cells. Although the COG complex has been largely
detected at the established perinuclear Golgi location in neurons
(Figure 1) this does not exclude some sort of moonlighting
function for COG subunits at other neuron-specific locations
where it could be involved in tethering of specialized vesicles.
Considering the systemic and complex character of COG-
related diseases, multiple questions regarding the associated
neurological symptoms remain to be addressed. Thus, more
in vivo studies are needed to dissect the role of COG and its
Rab and SNARE partners in these symptoms. Input from COG
deficiencies within neuroglia and subtypes of neuroglia presents
yet another poorly studied field and avenue requiring further
studies. Further research is also needed to establish in which
diseases COG-deficiency-associated neurological syndromes are
secondary manifestations of some other primary disease state.
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